NATASHA PEOPLES

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner GRAND RAPIDS, MI NPI 1356757173

General Payments — all program years on this page

$9,894.42

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 32
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $4,115.21 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Astellas Pharma US Inc $3,968.608
Novo Nordisk AS $53.373
Sumitomo Pharma America, Inc. $48.172
GlaxoSmithKline, LLC. $30.462
Acerta Pharma LLC $14.611

By program year

Program yearAmountRecords
2021 $39.372
2022 $216.364
2023 $5,523.4810
2024 $4,115.2116

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100346954 Novo Nordisk Inc $25.11 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100559419 Novo Nordisk Inc $15.05 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100595179 Novo Nordisk Inc $13.21 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105311369 AstraZeneca Pharmaceuticals LP $14.61 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116447626 GlaxoSmithKline, LLC. $13.92 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116703664 GlaxoSmithKline, LLC. $16.54 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139490936 Astellas Pharma US Inc $28.67 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139524558 Astellas Pharma US Inc $85.68 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139524560 Astellas Pharma US Inc $89.45 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139524562 Astellas Pharma US Inc $84.80 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139528890 Astellas Pharma US Inc $1,150.00 06/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1139528892 Astellas Pharma US Inc $1,150.00 05/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1139528894 Astellas Pharma US Inc $1,150.00 01/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1139559949 Astellas Pharma US Inc $230.00 11/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1148987404 Sumitomo Pharma America, Inc. $23.25 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148987406 Sumitomo Pharma America, Inc. $24.92 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.